Testosterone treatment and MMPI–2 improvement in transgender men: A prospective controlled study.

Keo-Meier, Colton L.; Herman, Levi I; Reisner, Sari L.; Pardo, Seth T.; Sharp, Carla; Babcock, Julia C.

doi:10.1037/a0037599

Cited by 87 publications

(84 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, high visual gender nonconformity and social transition were each associated with increased PTSD symptoms. Medical gender affirmation was significantly protective and associated with significantly decreased PTSD symptoms, which is consistent with prior research showing that medical gender affirmation is associated with positive mental health outcomes in transgender people (Colizzi, Costa, & Todarello, 2014; Gómez-Gil et al, 2012; Keo-Meier et al, 2014; E. C. Wilson, Chen, Arayasirikul, Wenzel, & Raymond, 2015).…”

Section: Discussionsupporting

confidence: 89%

Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults.

Reisner¹,

Hughto²,

Gamarel³

et al. 2016

Journal of Counseling Psychology

Self Cite

206

166

View full text Add to dashboard Cite

Discrimination has been shown to disproportionately burden transgender people; however, there has been a lack of clinical attention to the mental health sequelae of discrimination, including posttraumatic stress disorder (PTSD) symptoms. Additionally, few studies contextualize discrimination alongside other traumatic stressors in predicting PTSD symptomatology. The current study sought to fill these gaps. A community-based sample of 412 transgender adults (mean age 33, SD=13; 63% female-to-male spectrum; 19% people of color; 88% sampled online) completed a cross-sectional self-report survey of everyday discrimination experiences and PTSD symptoms. Multivariable linear regression models examined the association between self-reported everyday discrimination experiences, number of attributed domains of discrimination, and PTSD symptoms, adjusting for prior trauma, sociodemographics, and psychosocial co-morbidity. The mean number of discrimination attributions endorsed was 4.8 (SD=2.4) and the five most frequently reported reasons for discrimination were: gender identity and/or expression (83%), masculine and feminine appearance (79%), sexual orientation (68%), sex (57%), and age (44%). Higher everyday discrimination scores (β=0.25; 95% CL=0.21–0.30) and greater number of attributed reasons for discrimination experiences (β=0.05; 95% CL=0.01–0.10) were independently associated with PTSD symptoms, even after adjusting for prior trauma experiences. Everyday discrimination experiences from multiple sources necessitate clinical consideration in treatment for PTSD symptoms in transgender people.

show abstract

Section: Discussionsupporting

confidence: 89%

Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults.

Reisner¹,

Hughto²,

Gamarel³

et al. 2016

Journal of Counseling Psychology

Self Cite

206

166

View full text Add to dashboard Cite

show abstract

“…The most recent studies (since 2013) are discussed below and organized by type of behavioral health parameters measured. Eleven of these were longitudinal studies [33•, 34, 35•, 36•, 37, 38•, 39,40, 41•, 42•, 43], while the rest were cross-sectional studies. We highlight these 11 longitudinal studies in Table 1, since by design they provide more reliable data about GAHT effects on behavioral health as a function of time.…”

Section: Resultsmentioning

confidence: 99%

Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition

Nguyen

Chavez

Lipner

et al. 2018

Curr Psychiatry Rep

122

View full text Add to dashboard Cite

Purpose of Review With increasing numbers of transgender and gender non-binary individuals presenting for care, knowing how to elucidate the mental health and cognitive outcomes of gender-affirming hormone therapy (GAHT) is necessary. This article reviews the present literature covering GAHT effects on mood, behavioral health, and cognition in these individuals and offers research priorities to address knowledge gaps. Recent Findings Although there are some conflicting data, GAHToverwhelmingly seems to have positive psychological effects in both adolescents and adults. Research tends to support that GAHT reduces symptoms of anxiety and depression, lowers perceived and social distress, and improves quality of life and self-esteem in both male-to-female and female-to-male transgender individuals. Summary Clinically, prescribing GAHT can help with gender dysphoria-related mental distress. Thus, timely hormonal intervention represents a crucial tool for improving behavioral wellness in transgender individuals, though effects on cognitive processes fundamental for daily living are unknown. Future research should prioritize better understanding of how GAHT may affect executive functioning.

show abstract

“…64 By contrast, evidence is mounting that barriers to transition-related healthcare contribute to suicidality among those who desire such measures 63,78 and though it sometimes increases during transition, 78 it typically decreases once desired transitional goals are completed. 30,102 Indeed, a recent qualitative inquiry into suicide protective factors among trans adults identified several important protective factors among this population, one of which was socially and/or medically transitioning (for those who seek it). 103 Additionally, suicidality may be generally higher among transgender individuals than the general population throughout the life course, due to factors unrelated to transition, such as stigma and discrimination.…”

Section: Discussionmentioning

confidence: 99%

Varied Reports of Adult Transgender Suicidality: Synthesizing and Describing the Peer-Reviewed and Gray Literature

2017

View full text Add to dashboard Cite

Purpose: This article reports on the findings of a meta-synthesis undertaken on published gray transgender suicidality literature, to determine the average rate of suicidal ideation and attempts in this population.Methods: Studies included in this synthesis were restricted to the 42 that reported on 5 or more Canadian or U.S. adult participants, as published between 1997 and February 2016 in either gray or peer-reviewed health literature.Results: Across these 42 studies an average of 55% of respondents ideated about and 29% attempted suicide in their lifetimes. Within the past year, these averages were, respectively, 51% and 11%, or 14 and 22 times that of the general public. Overall, suicidal ideation was higher among individuals of a male-to-female (MTF) than female-to-male (FTM) alignment, and lowest among those who were gender non-conforming (GNC). Conversely, attempts occurred most often among FTM individuals, then decreased for MTF individuals, followed by GNC individuals.Conclusion: These findings may be useful in creating targeted interventions that take into account both the alarmingly high rate of suicidality in this population, and the relatively differential experience of FTM, MTF, and GNC individuals. Future research should examine minority stress theory and suicidality protection/resilience factors, particularly transition, on this population.

show abstract

Testosterone treatment and MMPI–2 improvement in transgender men: A prospective controlled study.

Cited by 87 publications

References 62 publications

Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults.

Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults.

Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition

Varied Reports of Adult Transgender Suicidality: Synthesizing and Describing the Peer-Reviewed and Gray Literature

Contact Info

Product

Resources

About